Interplay between tumor cell-associated and circulating coagulation factors in establishing metastatic potential.

被引:0
|
作者
Palumbo, JS
Massari, JV
La Jeunesse, CM
Flick, MJ
Hu, ZW
Talmage, KE
Degen, JL
机构
[1] Cincinnati Childrens Hosp, Cincinnati, OH USA
[2] Univ Cincinnati, Sch Med, Cincinnati, OH USA
[3] Yale Univ, New Haven, CT USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
686
引用
收藏
页码:202A / 203A
页数:2
相关论文
共 50 条
  • [31] CORRELATION BETWEEN TUMOR-CELL LYSOSOMAL CATHEPSIN-B AND METASTATIC POTENTIAL
    SLOANE, BF
    HONN, KV
    SADLER, JG
    ROMINE, M
    TCHEN, TT
    TAYLOR, JD
    FEDERATION PROCEEDINGS, 1981, 40 (03) : 782 - 782
  • [32] TUMOR-ASSOCIATED ANTIGENIC DIFFERENCES BETWEEN THE PRIMARY AND THE DESCENDANT METASTATIC TUMOR-CELL POPULATIONS
    GORELIK, E
    FOGEL, M
    SEGAL, S
    FELDMAN, M
    JOURNAL OF SUPRAMOLECULAR STRUCTURE, 1979, : 184 - 184
  • [33] TUMOR-ASSOCIATED ANTIGENIC DIFFERENCES BETWEEN THE PRIMARY AND THE DESCENDANT METASTATIC TUMOR-CELL POPULATIONS
    GORELIK, E
    FOGEL, M
    SEGAL, S
    FELDMAN, M
    JOURNAL OF SUPRAMOLECULAR STRUCTURE, 1979, 12 (03): : 385 - 402
  • [34] Potential of circulating tumor DNA as a predictor of therapeutic responses to immune checkpoint blockades in metastatic renal cell carcinoma
    Yeon Jeong Kim
    Yumi Kang
    Jun Seop Kim
    Hyun Hwan Sung
    Hwang Gyun Jeon
    Byong Chang Jeong
    Seong Il Seo
    Seong Soo Jeon
    Hyun Moo Lee
    Donghyun Park
    Woong-Yang Park
    Minyong Kang
    Scientific Reports, 11
  • [35] Potential of circulating tumor DNA as a predictor of therapeutic responses to immune checkpoint blockades in metastatic renal cell carcinoma
    Kim, Yeon Jeong
    Kang, Yumi
    Kim, Jun Seop
    Sung, Hyun Hwan
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Lee, Hyun Moo
    Park, Donghyun
    Park, Woong-Yang
    Kang, Minyong
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [36] Cell-free Circulating Tumor DNA (ctDNA) in Metastatic Renal Cell Carcinoma (mRCC): Current Knowledge and Potential Uses
    Hahn, Andrew W.
    Nussenzveig, Roberto H.
    Maughan, Benjamin L.
    Agarwal, Neeraj
    KIDNEY CANCER, 2019, 3 (01) : 7 - 13
  • [37] Perioperative cyclooxygenase 2 inhibition to reduce tumor cell adhesion and metastatic potential of circulating tumor cells in non-small cell lung cancer
    Backhus, Leah M.
    Sievers, Eric
    Lin, Gloria Y.
    Castanos, Roberto
    Bart, Robert D.
    Starnes, Vaughn A.
    Bremner, Ross M.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2006, 132 (02): : 297 - 303
  • [38] Factors Predicting Discordance in HER2 Phenotype between Primary Tumor and Circulating Tumor Cells in Women with Metastatic Breast Cancer
    Janni, W.
    Schramm, A.
    Friedl, T. W. P.
    Schochter, E.
    Huober, J.
    Rack, B.
    Alunni-Fabbroni, M.
    Fasching, P. A.
    Taran, F-A.
    Hortkopf, A.
    Schneeweiss, A.
    Mueller, V.
    Aktas, B.
    Krawczyk, N.
    Pantel, K.
    Fehm, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 47 - 47
  • [39] Hemostatic factors contribute to tumor cell metastatic potential by a mechanism linked to natural killer cell function.
    Palumbo, JS
    Talmage, KE
    Massari, JV
    La Jeunesse, CM
    Flick, MJ
    Jirouskova, M
    Degen, JL
    BLOOD, 2004, 104 (11) : 198A - 198A
  • [40] Interplay between 15-lipoxygenase-1 and metastasis-associated antigen 1 in the metastatic potential of colorectal cancer
    Tuncer, S.
    Cagatay, S. Tuncay
    Keskus, A. G.
    Colakoglu, M.
    Konu, O.
    Banerjee, S.
    CELL PROLIFERATION, 2016, 49 (04) : 448 - 459